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Objective: Tendon injuries produce considerable morbidity, long-lasting disability, and
remainaconsiderablechallengeforcliniciansandpatients.Theobjectiveofthestudywas
to assess the effect of amnion-derived multipotent progenitor (AMP) cells and amnion-
derivedcellcytokinesolutiononAchillestendonhealingbyusingaratmodel.Methods:
Achilles tendons of Sprague-Dawley rats were exposed and transected. The distal and
proximal ends were injected with either saline, amnion-derived cell cytokine solution,
or AMP cells in a standardized fashion and then sutured by using a Kessler technique.
Tendons from each group (n = 6-13) were collected at weeks 1, 2, and 4 postoperatively
and assessed for material properties (ultimate tensile strength, Young modulus, yield
strength, and breaking strength). Tendons were also evaluated histologically for cross-
sectional area by using hematoxylin-eosin and trichrome stains. Results: Mechanical
testing showed that the Young modulus was signiﬁcantly higher in AMP cells–treated
tendons at week 4 compared with both saline-treated and amnion-derived cell cytokine
solution–treated tendons. Yield strength was signiﬁcantly higher in the AMP cells–
treatedgroupcomparedwithsaline-treatedcontrolsatweek4.Nosigniﬁcantdifferences
were observed between the study groups at weeks 1 and 2. Discussion: Amnion-derived
multipotent progenitor cells have a positive effect on healing tendons by improving
mechanical strength and elastic modulus during the healing process. The presented
ﬁndings suggest the clinical utility of AMP cells in facilitating the healing of ruptured
tendons. Both the Young modulus and yield strengths of tendons increased signiﬁcantly
following treatment with AMP cells.
This study was supported by Stemnion Inc, Pittsburgh, Pa
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The healing of tendon injuries such as tears or lacerations represent a considerable
challenge.1 Tendon healing is a slow process, lasting for months, that aims to reestablish
tendon ﬁber continuity and strength.2 The tendon healing process occurs in 3 phases
starting with the inﬂammatory phase, that is characterized by proinﬂammatory molecules
and numerous cytokines and growth factors, recruiting ﬁbroblasts and local tenocytes.2
In the proliferative phase, the cells begin to synthesize the extracellular matrix, primarily
type III collagen. Finally, the tendon enters the remodeling phase, where the initial type III
collagen is replaced by collagen type I and organized longitudinally along the tendon axis
over a long period of time.3 However, tendon healing frequently results in the formation of
scars that reduce functionality.3
Modalities that speed up the healing process present a great clinical value. Growth
factorshaveshowntoplayanessentialroleinmediatingthetendonhealingprocess.4,5Vas-
cular endothelial growth factor,6 platelet-derived growth factor,7 and transforming growth
factor,7,8 among others, have been shown to be markedly upregulated following tendon
injury and are active at multiple stages of the healing process.
Stem cells and stem cell-like multipotent cells are deﬁned by their ability to differen-
tiate into several different cell types.9,10 They are also known to produce cytokine growth
factors that serve as mediators to the cellular processes of the wound-healing cascade, thus
enhancing regeneration.11,12 Amnion-derived cells share numerous characteristics with
stem cells, including differentiation potential.13,14 They also have been shown to secrete
a number of cytokines and growth factors15 essential to tendon regeneration. In previous
studies, amnion-derived multipotent progenitor (AMP) cells have shown a positive effect
on mechanical properties in an acute healing model in abdominal fascia in rats.16
The hypothesis of this study was that the rate of tendon repair and the mechanical
properties after tendon injury can be improved by intratendinous injection of cultured
human AMP cells and amnion derived cellular cytokine solution (ACCS).
METHODS
Cell and cytokine solution preparation
Amnion-derived multipotent progenitor cells were provided by Stemnion Inc (Pittsburgh,
Pa). Amnion cells were harvested from human placentas delivered at the time of caesarean
delivery. The cells were transported frozen and thawed immediately before experimental
application.
Amnion-derived multipotent progenitor cells were grown to conﬂuence, and the su-
pernatant was harvested.11 The secreted product, labeled ACCS, was used as one of the
treatment modalities in the study. Detailed analysis of the secreted growth factor and cy-
tokine proﬁle, including, but not limited to, platelet-derived growth factor-BB, vascular
endothelial growth factor, angiogenin, tissue inhibitor of metalloproteinase-1, and tissue
inhibitor of metalloproteinase-2, has previously been reported.11
Animals
One hundred twenty-six female Sprague-Dawley rats (Charles River, Cambridge, Mass),
weighing approximately 300 g and 10 weeks old, were used in this experiment. Two
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animals were kept per cage and given food and water ad libitum. Each cage (n = 63)
was randomly assigned to 3 different groups: saline (control), ACCS, and AMP cells. The
study was approved by the Harvard Medical Area standing committee on animals (protocol
#04794), and all institutional guidelines for the care and treatment of laboratory animals
were followed.
Surgical procedure
Rats were anesthetized with ketamine (60 mg/kg intraperitoneal; Phoenix, St Joseph, Mo)
and xylazine (10 mg/kg intraperitoneal; Vedco INC, St Joseph, Mo) and maintained by
using isoﬂurane gas (1%-2%) via nose cone. The right hind leg was shaved and then steril-
ized by using 70% alcohol, betadine, and 70% alcohol sequentially. Using sharp dissection,
the Achilles tendon was exposed and transected at its midpoint (Fig 1). The distal and
proximal ends were injected with either 100-μL saline, 100-μL ACCS, or 100 000 AMP
cells diluted in 100-μL phosphate-buffered saline. The ends were proximated and repaired
by using a modiﬁed Kessler technique17,18 with 6-0 ethylene-braided sutures (Ethicon,
Somerville, NJ) (Fig 2). Skin was closed, using 6-0 nylon sutures (Ethicon). The right hind
limb was then wrapped in petroleum gauze and then immobilized by using a casting tape
(ScotchcastTMPlus (3M, St. Paul, MN)) that was applied from the toes to the abdomen,
achieving 3-point stability (ankle-knee-hip).19 The animals were then returned to their cage
andallowedtohealforeither1,2,or4weeks.Ratswereobserveddailyforsignsofappetite,
pain, infection, swelling, and muscle paralysis. Rats were given buprenex (0.05 mg/kg sub-
cutaneous; Reckitt Benckiser Healthcare, Hull, England, United Kingdom) postoperatively
forupto48hours.Allcastswereremoved1-weekpostproceduretoallowweight-bearing.20
Figure1. Achillestendondissectionandrepair.(a)SharpdissectionwasusedtoexposetheAchilles
tendon. (b) Achilles tendon transection. 100 μL of amnion-derived cell cytokine solution, amnion-
derived multipotent progenitor cells, or saline (control) were injected in both proximal and distal
ends of the tendon. (c) The tendon was approximated, using a Kessler technique with a 6-0 braided
suture.
Animals were euthanized by isoﬂurane overdose (10%), and Achilles tendons were
dissected free from the extraneous soft tissue and harvested together with the calcaneal
bone and parts of the gastrocnemius and soleus muscle complex. The mechanical testing
specimens were immediately frozen at −80◦C. Specimens for histology were dissected in
a similar manner without the calcaneus. Contralateral uninjured tendons from each animal
were harvested as controls (Fig 3).
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Figure 2. Tensile testing setup. After harvest of the tendons,
the distal and proximal ends of each specimen were gripped,
using Pennington clamps. The Pennington clamps were se-
cured in the materials testing machine by using pneumatic
grips.
Mechanical testing
On the day of evaluation, specimens were thawed to room temperature and prepared for
mechanical testing. The muscle was carefully separated from the proximal tendon by blunt
dissection to produce a fan of tendon ﬁbers21 that were then gripped by using a large
Pennington clamp (Johnson & Johnson, New Brunswick, NJ). The distal end of the tendon
was then gripped by using another Pennington clamp proximal to the calcaneal insertion
(Fig 4). The 2 Pennington clamps were then vertically secured in an Instron 5565 mate-
rial testing system (Instron, Norwood, Mass) by using pneumatic grips with serrated jaw
faces. Tendon width, thickness, and length (distance between Pennington clamp ends) were
recorded by using a slide caliper.21 The cross-sectional area was calculated, assuming cir-
cular tendon geometry. Tendons were kept moist by using gauze with saline throughout
testing.
Tendons were preconditioned for 3 cycles at 2% extension immediately followed by a
load-to-failuretestataspeedof6mm/min.22 Loadingforcewasmeasuredbyusinga100-N
load cell, and all data were collected with Blue-Hill 2 software (Instron). Breaking strength
(deﬁned as maximum force), stiffness (force required per unit displacement), tensile strain
(deﬁnedaschangeinlengthoverinitiallengthmm/mm),ultimatetensilestrength(deﬁnedas
maximum stressorforce perunit area),yieldstrength(deﬁned as maximumstressin elastic
region), and Young modulus (a measure of a material’s resistance to elastic deformation)
were obtained, and engineering stress versus engineering strain curves generated.
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Figure 3. Results of mechanical testing. The results of the mechanical testing are presented in
regard to the following parameters: ultimate tensile strength (maximum stress or force per unit
area), Young modulus (resistance to elastic deformation), yield strength (maximum stress in elastic
region), cross-sectional area, breaking strength (maximum force), and stiffness (force required per
unit displacement). ACCS indicates amnion-derived cell cytokine solution; AMP, amnion-derived
multipotent progenitor cells.
Figure4. Histologicalevaluation2weeksaftertendonrepair.Hematoxylin-eosinstainingoftendons
injected with saline (a), amnion-derived cell cytokine solution (b), and amnion-derived multipotent
progenitorcells(c)2weeksafterrepair.CorrespondingserialsectionsstainedwithMassontrichrome
(d-f).
Histology
The tendons were immersed in 10% formalin for 24 hours and then rinsed in phosphate-
buffered saline. Tendons were then cut longitudinally for histological evaluation. Parafﬁn-
embedded sections were mounted onto slides and stained with hematoxylin-eosin and
Masson trichrome, using standard protocols. An average of 3 transverse measurements
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taken at the midpoint, proximal end, and distal end was used to calculate tendon diameter
and transverse cross-sectional area.
Statistical analysis
Data were subjected to 2-way analysis of variance, with treatment and time as independent
factors. A Bonferroni post hoc test was used to determine statistical signiﬁcance. A P value
< .05 was considered statistically signiﬁcant. All values are given as mean±SD.
RESULTS
Material properties
One hundred twenty-six rat Achilles tendons were transected, injected with saline, ACCS,
orAMPcells,thensutured,andallowedtohealfor1,2,or4weeksbeforebeingeuthanized.
Overall, the surgical procedure was well tolerated, with a total of 2 rats (1.5%) lost post-
operatively. No discernible differences in any material properties were observed between
specimens at the 1-week time point. Because of the fragile nature of the healing tendons,
especially at the 1-week time point, tendons that showed incomplete healing due to rupture
were excluded (n = 30).
Ultimate tensile strength
TheAMPcells–treatedtendonsdemonstratedhigherultimatetensilestrengthatbothweeks
2( 4 . 2±1.68 MPa) and 4 (7.16±2.16 MPa) than saline-treated controls (2.9±0.54 MPa
and 4.78±1.63 MPa, respectively). These differences were not statistically signiﬁcant.
Young modulus
The AMP cells–treated tendons exhibited signiﬁcantly higher (P < .005) Young modulus
at week 4 (0.25±0.02 MPa) than saline-treated (0.09±0.04 MPa) and ACCS-treated
(0.12±0.020 MPa) tendons at the same time point. Uninjured tendons were found to have
a Young modulus of 0.33±0.16 MPa.
Yield strength
The yield strength of AMP cells–treated tendons (4.2±0.83 MPa) was also signiﬁcantly
higher (P < .05) than saline-treated controls (2.93±0.54 MPa) at week 4.
Breaking strength and stiffness
As expected, the maximum force (breaking strength) sustained by the tendon specimens as
well as tendon stiffness increased with time; however, no statistical signiﬁcance was seen
between treatment groups.
A summary of all measured parameters is given in Table 1.
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Table 1. Summary of mechanical properties
Week 1, M±SD
Control ACCS AMP cells
Ultimate tensile strength, MPa 2.75±1.84 3.19±2.6 1.47±0.71
Young modulus, MPa 0.14±0.06 0.08±0.02 0.06±0.05
Breaking strength, N 21.3±10.7 19.5±6.33 10.4±6.48
Stiffness, N/mm 13.57±6.75 14.88±5.28 9.67±5.69
Week 2, M±SD
Control ACCS AMP cells
Ultimate tensile strength, MPa 2.9±0.54 2.9±0.72 4.2±1.68
Young modulus, MPa 0.06±0.02 0.06±0.02 0.12±0.08
Breaking strength, N 38.2±4.29 28.9±10.13 37.35±6.5
Yield, MPa 1.55±0.35 1.97±0.41 2.39±1.33
Stiffness, N/mm 15.5±0.71 11.57±4.32 17.78±6.59
Cross-sectional area, mm2 3.49±0.44 5.72±2.03 4.64±1.65
Week 4, M±SD
Control ACCS AMP cells
Ultimate tensile strength, MPa 4.78±1.63 5.89±1.12 7.16±2.16
Young modulus, MPa 0.09±0.04 0.12±0.02 0.25±0.02
Breaking strength, N 39.98±11.68 45.64±3.89 41.39±7.13
Yield, MPa 2.93±0.54 3.14±0.96 4.2±0.83
Stiffness, N/mm 24.71±5.5 21.63±6.48 27.5±4.81
Cross-sectional area, mm2 3.44±1.63 4.78±1.86 8.93±1.93
ACCSindicatesamnion-derivedcellcytokinesolution;AMP,amnion-derivedmultipotentprogenitor;SD,standard
deviation.
Figure5. Histologicalevaluation4weeksaftertendonrepair.Hematoxylin-eosinstainingoftendons
injected with saline (a), amnion-derived cell cytokine solution (b), and amnion-derived multipotent
progenitorcells(c)4weeksafterrepair.CorrespondingserialsectionsstainedwithMassontrichrome
(d-f).
Histology
Histological examination revealed noticeable gapping at the site of repair 1-week postpro-
cedure(datanotshown).TheAMPcells–andACCS-treatedtendonswere visiblythickerat
time points 2 and 4 weeks (Figs 4 and 5). The trichrome staining reveals a relative increase
in amount of collagen in samples 4-week postprocedure, most apparent in tendons treated
with AMP cells (Fig 5).
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Cross sectional area
Both AMP cells– and ACCS-treated tendons showed a signiﬁcant (P < .01 and P < .05,
respectively) increase in cross-sectional area compared with saline-treated controls 4-week
postprocedure (Fig 3).
DISCUSSION
The results obtained in this study reveal that treatment of transected tendons with AMP
cells has a beneﬁcial effect in regard to the material properties of the healed tendons at 4
weeks.TheresultsobtainedinthisstudyaresimilartothosereportedpreviouslybyEliasson
et al.23
As t u d yb yC l a v e r te ta l24 concludes that freezing and thawing of human tendons had
no inﬂuence on the tendinous relaxation but altered signiﬁcantly the ultimate tensile failure
and Young modulus of the tendons. However, a recent study in a porcine model suggests
thatfreezingandthawingoftendonsdoesnotaltertheirtensilepropertiesinacyclicloading
model.25 Another recent study in a cadaveric human tendon model has proven that fewer
than 3 cycles of freezing and thawing did not inﬂuence biomechanical properties.26 In this
study, any effect attributed to freezing and thawing of tendons is equal for all study groups
and hence would not alter the results.
Signiﬁcant differences were found in the measurements of yield strength and elastic
modulus.
Yield strength is the maximum stress a material can sustain before being plastically
(permanently)deformed.Thus,inaphysicalsense,yieldstrengthmarkstheupperthreshold
to which a tendon can be stressed. Higher yield strength of a tendon allows for a higher
energydissipationcapacity.ThetendonstreatedwithAMPcellsdisplaysigniﬁcantlyhigher
yield strength 4-week postprocedure than the control group.
Young modulus is a measure of the relative stiffness/elastic modulus of a material.
The closer the Young modulus of a healed tendon is to that of a normal, uninjured tendon,
the more similarly it will behave under mechanical stress. Excessive stiffness (by 2 or more
orders of magnitude) over normal is not desirable as the tendons will display a diminished
ability to withstand deformations under stress. In this experiment, the tendons treated with
AMP cells and allowed to heal for 4 weeks exhibited a signiﬁcant improvement in elastic
modulus over both saline-treated and ACCS-treated tendons at the same time point. In fact,
AMP cells–treated tendons were very close to values observed in untreated tendon by this
measurement. Even at the 2-week time point, a trend in the same direction was observed.
Ultimate tensile strength is a measure of the maximum stress that a material can
withstand while being subjected to stress. In this experiment, a trend for improved strength
was observed with the AMP cells–treated tendons, starting at the 2-week time point and
continuing to improve at the 4-week time point. However, this positive trend was not
statistically signiﬁcant.
The greater the tendon cross-sectional area, the greater the amount of new tissue
generated. This is an encouraging observation, particularly during the early phase of the
healing process as it provides better tendon strength. Hematoxylin-eosin and trichrome
stains of tendon samples revealed that the AMP cells-treated tendons at the 4-week time
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pointhadaconsiderablygreatertransversecross-sectionalareathaneithersaline-orACCS-
treated tendons.
Breaking strength measures the ability of a material to resist breaking or rupture from
a tension force. In these experiments, breaking strength did not exhibit any discernible
difference. However, at 2 weeks, more tissues had healed to the point where they could
undergo analysis by tension testing in both the ACCS- and AMP cells–treated groups,
suggesting that there was an earlier improvement in healing when treated with ACCS and
AMP cells as compared with saline.
The lack of improved healing of the ACCS-treated tendons may be explained by the
fact that the treatment was only performed once. The half-life of the cytokines in tissue
was not studied in this experimental setup, but the effects of enzymatic degradation are
apparent. This can also explain the positive healing outcome after treatment with AMP
cells. The cells likely remain present at the healing site and, in addition to any direct effect
on tissue remodeling, could produce active molecules that recruit endogenous cells that
improve the tendon healing. The immune privilege of human amnion-derived cells allowed
us to apply human AMP cells as a xenoraft in this rat model.27
CONCLUSIONS
This study demonstrates that tendons treated with AMP cells displayed improved healing
at 2 and 4-week postprocedure. Treatment with AMP cells appears to provide the great-
est effect at the 4-week time point. It is theorized that this is because the cells provide
a continuous supply of the necessary secreted factors, while the ACCS is essentially a
single-dose delivery. Future experiments will test sustained-release delivery of ACCS and
should include later time points to determine whether improvement in tendon material
properties continues. AMP cells–treated tendons demonstrated a more rapid healing rate
and restoration of normal material properties, especially with respect to Young modulus
and yield strength.
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